None
Conditions
Interventions
The oxelidine combined with cyclopofol group:oselidine 20ug/kg, combined with cyclophenol induction dose of 0.4mg/kg as a sedative, the injection speed was not less than 30 seconds, when the oaa/s sco
Sufentanil combined with cyclopofol group:Sufentanil 0.1ug/kg, combined with cyclophenol induction dose of 0.4mg/kg as a sedative, the injection speed shall not be less than 30 seconds, when the oaa/s
Sponsors
No.215 Hospital of Shaanxi Nuclear Industry
Eligibility
Sex/Gender
All
Age
18 Years to 64 Years
Inclusion criteria
Inclusion criteria: 1.Patients between 18 and 64 years of age; 2.BMI:18.5~29.9kg/m^2; 3.ASA Grade I to II and stable state ASA Grade III; 4.Patients scheduled for painless gastroscopy and colonoscopy.
Exclusion criteria
Exclusion criteria: 1.Patients with severe heart, lung, liver, kidney and other organ dysfunction; 2.Those who have a clear history of narcotic drugs or are allergic to drug-related components; 3.A history of uncured acute respiratory tract infection within 14 days; 4.Those who have been taking antidepressants, anxiety drugs and other psychotropic drugs, as well as sedatives and analgesics for a long time; 5.Patients who are unable to communicate normally through speech; 6.Patients undergoing special treatment under gastroscopy and colonoscopy; 7.Obvious difficult airway.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The quality of anesthesia recovery (QoR-15) score 24 hours after the operation.; | — |
Secondary
| Measure | Time frame |
|---|---|
| The dosage of vasoactive drugs;Hemodynamic Parameters;Total cyclopofol;Inspection time;Check for adverse reactions during the operation.;Adverse reactions in the recovery room;Recovery time;The duration of stay in the PACU; | — |
Countries
China
Contacts
Public ContactLiuqin Jiang
No.215 Hospital of Shaanxi Nuclear Industry
Outcome results
None listed